| Ident. | Authors (with country if any) | Title |
|---|
| 000010 (2021) |
Nicole Fagan [Irlande (pays)] ; Nekma Meah [Australie] ; Katherine York [Afrique du Sud] ; Laita Bokhari [Australie] ; Godfrey Fletcher [Irlande (pays)] ; Gang Chen [Australie] ; Desmond J. Tobin [Irlande (pays)] ; Andrew Messenger [Royaume-Uni] ; Alan D. Irvine [Irlande (pays)] ; Rodney Sinclair [Australie] ; Dmitri Wall [Irlande (pays)] | Shedding light on therapeutics in alopecia and their relevance to COVID-19. |
| 000031 (2021) |
Hülya Gamze Çelik [Turquie] ; Iran Keske [Turquie] ; Ülker Ener [Turquie] ; Müge Tekba [Turquie] ; Mahir Kapmaz [Turquie] ; Krü Taylan Ahin [Turquie] ; Asl Özy Ld R M [Turquie] ; Saide Aytekin [Turquie] ; Vedat Aytekin [Turquie] ; Önder Ergönül [Turquie] | Why we should be more careful using hydroxychloroquine in influenza season during COVID-19 pandemic? |
| 000056 (2021) |
Jessica S C. Leung [Hong Kong] ; Maurice M W. Cheng [Nouvelle-Zélande] | Trust in the time of corona: epistemic practice beyond hard evidence. |
| 000078 (2021) |
Ales Janda [Allemagne] ; Catharina Schuetz [Allemagne] ; Scott Canna [États-Unis] ; Mark Gorelik [États-Unis] ; Maximilian Heeg [Allemagne] ; Kirsten Minden [Allemagne] ; Claas Hinze [Allemagne] ; Ansgar Schulz [Allemagne] ; Klaus-Michael Debatin [Allemagne] ; Christian M. Hedrich [Royaume-Uni] ; Fabian Speth [Allemagne] | Therapeutic approaches to pediatric COVID-19: an online survey of pediatric rheumatologists. |
| 000084 (2021) |
Bhanu Prasad Venkatesulu [États-Unis] ; Viveksandeep Thoguluva Chandrasekar [États-Unis] ; Prashanth Giridhar [Inde] ; Pragathee V [Inde] ; Harsh K. Patel [États-Unis] ; Jacob Manteuffel [États-Unis] | The mechanistic rationale of drugs, primary endpoints, geographical distribution of clinical trials against severe acute respiratory syndrome-related coronavirus-2: A systematic review. |
| 000107 (2021) |
O O Oleribe [Nigeria] ; P. Oskouipour [États-Unis] ; O. Nwanyanwu [États-Unis] ; S D Taylor-Robinson [Royaume-Uni] | The COVID-19 era: the view from Nigeria. |
| 000185 (2021) |
Sonsoles Salto-Alejandre [Espagne] ; Silvia Jiménez-Jorge [Espagne] ; Nuria Sabé [Espagne] ; Antonio Ramos-Martínez [Espagne] ; Laura Linares [Espagne] ; Maricela Valerio [Espagne] ; Pilar Martín-Dávila [Espagne] ; Mario Fernández-Ruiz [Espagne] ; María Carmen Fari As [Espagne] ; Marino Blanes-Juliá [Espagne] ; Elisa Vidal [Espagne] ; Zaira R. Palacios-Baena [Espagne] ; Román Hernández-Gallego [Espagne] ; Jordi Carratalá [Espagne] ; Jorge Calder N-Parra [Espagne] ; María Ángeles Marcos [Espagne] ; Patricia Mu Oz [Espagne] ; Jesús Fortún-Abete [Espagne] ; José María Aguado [Espagne] ; Francisco Arnaiz-Revillas [Espagne] ; Rosa Blanes-Hernández [Espagne] ; Julián De La Torre-Cisneros [Espagne] ; Luis E. L Pez-Cortés [Espagne] ; Elena García De Vinuesa-Calvo [Espagne] ; Clara M. Rosso [Espagne] ; Jer Nimo Pach N [Espagne] ; Javier Sánchez-Céspedes [Espagne] ; Elisa Cordero [Espagne] | Risk factors for unfavorable outcome and impact of early post-transplant infection in solid organ recipients with COVID-19: A prospective multicenter cohort study. |
| 000299 (2021) |
Marko Boban [Croatie] | Novel coronavirus disease (COVID-19) update on epidemiology, pathogenicity, clinical course and treatments. |
| 000306 (2021) |
Pobitra Borah [Inde] ; Pran Kishore Deb [Jordanie] ; Balakumar Chandrasekaran [Jordanie] ; Manoj Goyal [Arabie saoudite] ; Monika Bansal [Arabie saoudite] ; Snawar Hussain [Arabie saoudite] ; Pottathil Shinu [Arabie saoudite] ; Katharigatta N. Venugopala [Afrique du Sud] ; Nizar A. Al-Shar'I [Jordanie] ; Satyendra Deka [Inde] ; Vinayak Singh [Afrique du Sud] | Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiatric Adverse Events in COVID-19 Patients: Navigating the Uncharted. |
| 000327 (2021) |
Yashwant Kumar Ratre [Inde] ; Namrata Kahar [Inde] ; L V K S. Bhaskar [Inde] ; Antaripa Bhattacharya [Italie] ; Henu Kumar Verma [Italie] | Molecular mechanism, diagnosis, and potential treatment for novel coronavirus (COVID-19): a current literature review and perspective. |
| 000355 (2021) |
Jacques Fantini [France] ; Henri Chahinian [France] ; Nouara Yahi [France] | Leveraging coronavirus binding to gangliosides for innovative vaccine and therapeutic strategies against COVID-19. |
| 000391 (2021) |
Yufeng Shang [République populaire de Chine] ; Tao Liu [République populaire de Chine] ; Jingfeng Li [République populaire de Chine] ; Natasha Mupeta Kaweme [République populaire de Chine] ; Xinghuan Wang [République populaire de Chine] ; Fuling Zhou [République populaire de Chine] | Impact of Treatment Regimens on Antibody Response to the SARS-CoV-2 Coronavirus. |
| 000417 (2021) |
Alasdair Macgowan [Royaume-Uni] ; Fergus Hamilton [Royaume-Uni] ; Mark Bayliss [Royaume-Uni] ; Liam Read [Royaume-Uni] ; Marie Attwood [Royaume-Uni] ; Alan Noel [Royaume-Uni] ; Sally Grier [Royaume-Uni] ; Anna Morley [Royaume-Uni] ; David Arnold [Royaume-Uni] ; Nicholas Maskell [Royaume-Uni] | Hydroxychloroquine serum concentrations in non-critical care patients infected with SARS-CoV-2. |
| 000480 (2021) |
Anamika Gupta [Inde] ; Rumana Ahmad [Inde] ; Sahabjada Siddiqui [Inde] ; Kusum Yadav [Inde] ; Aditi Srivastava [Inde] ; Anchal Trivedi [Inde] ; Bilal Ahmad [Inde] ; Mohsin Ali Khan [Inde] ; Amit Kumar Shrivastava [Népal] ; Girish Kumar Singh [Inde] | Flavonol morin targets host ACE2, IMP-α, PARP-1 and viral proteins of SARS-CoV-2, SARS-CoV and MERS-CoV critical for infection and survival: a computational analysis. |
| 000500 (2021) |
Avinash Kumar Jha [Royaume-Uni] ; Sudhindra Gurunath Kulkarni [Royaume-Uni] | Evolution of COVID-19 management in critical care: review and perspective from a hospital in the United Kingdom. |
| 000516 (2021) |
Yi Su [République populaire de Chine] ; Yun Ling [République populaire de Chine] ; Yuyan Ma [République populaire de Chine] ; Lili Tao [États-Unis] ; Qing Miao [République populaire de Chine] ; Qingfeng Shi [République populaire de Chine] ; Jue Pan [République populaire de Chine] ; Hongzhou Lu [République populaire de Chine] ; Bijie Hu [République populaire de Chine] | Efficacy of early hydroxychloroquine treatment in preventing COVID-19 pneumonia aggravation, the experience from Shanghai, China. |
| 000563 (2021) |
Nicholas Agresti [États-Unis] ; Jacob P. Lalezari [États-Unis] ; Phillip P. Amodeo [États-Unis] ; Kabir Mody [États-Unis] ; Steven F. Mosher [États-Unis] ; Harish Seethamraju [États-Unis] ; Scott A. Kelly [États-Unis] ; Nader Z. Pourhassan [États-Unis] ; C David Sudduth [États-Unis] ; Christopher Bovinet [États-Unis] ; Ahmed E. Elsharkawi [États-Unis] ; Bruce K. Patterson [États-Unis] ; Reejis Stephen [États-Unis] ; Jonah B. Sacha [États-Unis] ; Helen L. Wu [États-Unis] ; Seth A. Gross [États-Unis] ; Kush Dhody [États-Unis] | Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab. |
| 000571 (2021) |
Mukesh Kumar [Inde] ; Jitender Madan [Inde] ; Rupinder Kaur Sodhi [Inde] ; Shashi Bala Singh [Inde] ; Anju Katyal [Inde] | Decoding the silent walk of COVID-19: Halting its spread using old bullets. |
| 000685 (2021) |
Berta Saez-Giménez [Espagne] ; Cristina Berastegui [Espagne] ; Miriam Barrecheguren [Espagne] ; Eva Revilla-L Pez [Espagne] ; Ibai Los Arcos [Espagne] ; Rodrigo Alonso [Espagne] ; Myriam Aguilar [Espagne] ; Víctor M. Mora [Espagne] ; Isabel Otero [Espagne] ; Juan P. Reig [Espagne] ; Carlos A. Quezada [Espagne] ; Virginia Pérez [Espagne] ; Manuel Valle [Espagne] ; Rosalía Laporta [Espagne] ; María Deu [Espagne] ; Judith Sacanell [Espagne] ; Carles Bravo [Espagne] ; Joan Gavalda [Espagne] ; Manuel Lopez-Meseguer [Espagne] ; Víctor Monforte [Espagne] | COVID-19 in lung transplant recipients: A multicenter study. |
| 000692 (2021) |
Desley Butters [Australie] ; Michael Whitehouse [Australie] | COVID-19 and nutriceutical therapies, especially using zinc to supplement antimicrobials. |
| 000700 (2021) |
Adebayo Adeyinka ; Keneisha Bailey ; Louisdon Pierre ; Noah Kondamudi | COVID 19 infection: Pediatric perspectives. |
